Interesting points @RickyH, yes I think as per hospital protocol, they'll probably be monitored, but if you look that list of primary and secondary outcomes on the clinical trials . gov listing, the ones that go beyond '30 days' are as follows..
1) Days alive off mechanical ventilation (60 days)
2) No. of participants alive at day 7/14/60/90 (Presumably after the 45% interim readout, if we're seeing overwhelming efficacy, the placebo arm will pivot to SOC incl. Rem-L infusion)
3) Hospital length of stay (12mth)
On an even more incredible note, their secondary outcomes measuring key inflammatory marker levels (IL-6, tnf-alpha, IL-8, serum hs-CRP) are capped off at 30 days. Its almost like they are expecting the turnaround well within 30days.
Overwhelming efficacy - the stats required, page-411
-
- There are more pages in this discussion • 166 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.45 |
Change
-0.030(2.03%) |
Mkt cap ! $1.655B | |||
| Open | High | Low | Value | Volume |
| $1.48 | $1.51 | $1.43 | $6.613M | 4.498M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2482 | $1.45 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.46 | 27045 | 2 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |